Line 6: |
Line 6: |
| **sub division | | **sub division |
| ***sub-sub-sub division | | ***sub-sub-sub division |
| + | |
| + | |
| + | |
| + | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities]] |
| + | |
| + | - [[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] |
| + | - [[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] |
| + | - [[Acute Promyelocytic Leukemia (APL) with PML-RARA]] |
| + | - [[Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] |
| + | - [[Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214]] |
| + | - [[Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] |
| + | - [[Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] |
| + | - [[Acute Myeloid Leukemia (AML) with BCR-ABL1]] |
| + | - [[Acute Myeloid Leukemia (AML) with Mutated NPM1]] |
| + | - [[Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA]] |
| + | - [[Acute Myeloid Leukemia (AML) with Mutated RUNX1]] |
| + | |
| + | *[[Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes]] |
| + | |
| + | *[[Therapy-Related Myeloid Neoplasms]] |
| + | |
| + | *[[Acute Myeloid Leukemia (AML), Not Otherwise Specified]] |
| + | |
| + | - [[Acute Myeloid Leukemia (AML) with Minimal Differentiation]] |
| + | - [[Acute Myeloid Leukemia (AML) without Maturation]] |
| + | - [[Acute Myeloid Leukemia (AML) with Maturation]] |
| + | - [[Acute Myelomonocytic Leukemia]] |
| + | - [[Acute Monoblastic and Monocytic Leukemia]] |
| + | - [[Pure Erythroid Leukemia]] |
| + | - [[Acute Megakaryoblastic Leukemia (AMKL)]] |
| + | - [[Acute Basophilic Leukemia]] |
| + | - [[Acute Panmyelosis with Myelofibrosis]] |
| + | |
| + | *[[Myeloid Sarcoma]] |
| + | |
| + | *[[Myeloid Proliferations Associated with Down Syndrome]] |
| + | |
| + | - [[Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome]] |
| + | - [[Myeloid Leukemia Associated with Down Syndrome]] |
| + | |
| + | *[[Blastic Plasmacytoid Dendritic Cell Neoplasm]] |
| + | |
| + | *[[Acute Leukemias of Ambiguous Lineage]] |
| + | |
| + | - [[Acute Undifferentiated Leukemia]] |
| + | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]] |
| + | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]] |
| + | - [[Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified]] |
| + | - [[Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]] |
| + | - [[Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types]] |
| + | - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] |
| + | |
| + | *[[Myeloid Neoplasms with Germline Predisposition]] |
| + | |
| + | - [[Acute Myeloid Leukaemia with Germline CEBPA Mutation]] |
| + | - [[Myeloid Neoplasms with Germline DDX41 Mutation]] |
| + | - [[Myeloid Neoplasms with Germline RUNX1 Mutation]] |
| + | - [[Myeloid Neoplasms with Germline ANKRD26 Mutation]] |
| + | - [[Myeloid Neoplasms with Germline ETV6 Mutation]] |
| + | - [[Myeloid Neoplasms with Germline GATA2 Mutation]] |